Cargando…
Doxorubicin-Induced Oxidative Stress and Endothelial Dysfunction in Conduit Arteries Is Prevented by Mitochondrial-Specific Antioxidant Treatment
BACKGROUND: Doxorubicin (DOXO) chemotherapy increases risk for cardiovascular disease in part by inducing endothelial dysfunction in conduit arteries. However, the mechanisms mediating DOXO-associated endothelial dysfunction in (intact) arteries and treatment strategies are not established. OBJECTIV...
Autores principales: | Clayton, Zachary S., Brunt, Vienna E., Hutton, David A., VanDongen, Nicholas S., D’Alessandro, Angelo, Reisz, Julie A., Ziemba, Brian P., Seals, Douglas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561020/ https://www.ncbi.nlm.nih.gov/pubmed/33073250 http://dx.doi.org/10.1016/j.jaccao.2020.06.010 |
Ejemplares similares
-
Age-related Aortic Stiffness Can Be Transferred and Ameliorated via Fecal Microbiota Transplant in Mice.
por: Greenberg, Nathan, et al.
Publicado: (2021) -
Short‐term interleukin‐37 treatment improves vascular endothelial function, endurance exercise capacity, and whole‐body glucose metabolism in old mice
por: Ballak, Dov B., et al.
Publicado: (2019) -
Circulating interleukin-37 declines with aging in healthy humans: relations to healthspan indicators and IL37 gene SNPs
por: Brunt, Vienna E., et al.
Publicado: (2022) -
Promoting healthy cardiovascular aging: emerging
topics
por: Clayton, Zachary S., et al.
Publicado: (2022) -
Mitochondrial-targeted antioxidant supplementation for improving age-related vascular dysfunction in humans: A study protocol
por: Murray, Kevin O., et al.
Publicado: (2022)